Clinical trials
Recruiting Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
467 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 12 |
| 2019 | 10 |
| 2020 | 21 |
| 2021 | 20 |
| 2022 | 40 |
| 2023 | 63 |
| 2024 | 81 |
| 2025 | 103 |
| 2026 | 82 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 467 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundación EPIC | 13 |
| China National Center for Cardiovascular Diseases | 12 |
| Seung-Jung Park | 12 |
| Samsung Medical Center | 7 |
| Shanghai Zhongshan Hospital | 7 |
| University of Florida | 7 |
| Insel Gruppe AG, University Hospital Bern | 6 |
| Nanjing First Hospital, Nanjing Medical University | 6 |
| Ruijin Hospital | 6 |
| National Institute of Cardiology, Warsaw, Poland | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 467 |
| Myocardial Ischemia | 35 |
| Cardiovascular Diseases | 31 |
| Atherosclerosis | 30 |
| Acute Coronary Syndrome | 29 |
| Coronary Disease | 23 |
| Coronary Stenosis | 23 |
| Myocardial Infarction | 23 |
| Heart Failure | 19 |
| Angina Pectoris | 18 |
Trials
Showing 26 to 50 of 467. Each trial links to its page on Pharma Observatory.
367 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.